Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 7c, reiterates guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.94, $0.07 better than the analyst estimate of $1.87. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY 2024 EPS of $8.00-$8.15, versus the consensus of $8.05.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Macy's (M) Tops Q1 EPS by 10c, Beats on Revenue; Offers FY27 Guidance
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance